ProPhase Labs, Inc. (PRPH) Total liabilities 2016–2025
ProPhase Labs, Inc. (PRPH) total liabilities at each fiscal year-end, per SEC filings.
$56.4MFY2025 · since FY2016: $6.8M → $56.4M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $56.4M | +0.9% |
| FY2024 | $55.8M | +31.3% |
| FY2023 | $42.5M | +77.1% |
| FY2022 | $24.0M | -21.7% |
| FY2021 | $30.7M | +47.1% |
| FY2020 | $20.8M | +1898.9% |
| FY2019 | $1.0M | -75.4% |
| FY2018 | $4.2M | +133.6% |
| FY2017 | $1.8M | -73.5% |
| FY2016 | $6.8M | — |
Years the filer does not tag total liabilities directly are shown as reported total assets − reported shareholders’ equity at the same fiscal year-end.
Source: SEC XBRL filings · For reference only · Not investment advice
More PRPH financial trends
PRPH RevenuePRPH Net incomePRPH Net marginPRPH Gross profitPRPH Gross marginPRPH Operating incomePRPH Operating marginPRPH Operating cash flowPRPH Free cash flowPRPH Capital expendituresPRPH Return on equityPRPH Stock buybacksPRPH Dividends paidPRPH Total assetsPRPH Shareholders’ equityPRPH overview →